Benjamin Looker Esperion Therapeutics, Inc. (ESPR) insider trading activity
Benjamin Looker is General Counsel of Esperion Therapeutics, Inc.. Currently has a direct ownership of 385,905 shares of ESPR, which is worth approximately $1.12 Million. The most recent transaction as insider was on Dec 17, 2025, when has been sold 6,517 shares (Common Stock) at a price of $3.67 per share, resulting in proceeds of $23,917. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
386K
1.97%
3M change
110.12%
12M change
Total Value Held
$1.12 Million
Benjamin Looker Transaction History
BL
Benjamin Looker
General Counsel
Ann Arbor, MI